AARSOTA Cancer Vaccine


AARSOTA Cancer Vaccine

Autologous Antigen Receptor Specific Oncogenic Target Acquisition(AARSOTA) Cancer Vaccine.

This cancer vaccine is administered at specific intervals to promote your antigen antibody response and provide immunological information to your antibodies. The immunological response enhances a specific cancer fighting ability in your body's defense system.

How it works

Tumor markers are measurable bio-chemicals that are associated with a cancer or malignancy. They are either produced by tumor cells (tumor-derived) or by your body in response to tumor cells (tumor-associated). They are substances that are released into the circulation and thus present in your blood. Though tumor markers are rarely specific enough to be used alone to diagnose cancer, they do have a number of clinical uses.

We have the technology and expertise required to extract, from your urine, the proteins that are produced by the cancer cells and then develop a vaccine. This vaccine is administered at specific intervals to promote your antigen-antibody response and provide immunological information to the antibodies. The immunological response enhances specific cancer fighting ability in your body.